PHI’s new HoloMonitor M4FL premiers at major scientific conferences

May 24, 2023
Language flag

Phase Holographic Imaging (PHI) introduces the HoloMonitor M4FL system to the global scientific community at two major scientific conferences this June.

In Europe, PHI exhibits at the 2023 Annual Congress of the European Association for Cancer Research (EACR 2023) in Torino, Italy. In the US, PHI is showcasing at the International Society for Stem Cell Research 2023 Annual Meeting (ISSCR 2023) in Boston, Massachusetts. These events mark the product’s world premiere.

With this latest product portfolio addition, we combine the HoloMonitor M4 system and its key technology – cell-friendly holographic microscopy – with fluorescence microscopy.
We are eager to speak to many researchers at the upcoming conferences and demonstrate how we push the boundaries of non-invasive live cell imaging from cancer research to regenerative medicine.

Lisa Lindström, PHI product manager
FL

More information about the new HoloMonitor M4FL can be found online at phiab.com/holomonitor/fluorescence/.

Subscribe to PHI news on cision.com

Latest News

Directed issue registered at the Companies Registration Office

PHI Board of Directors’ proposal on a directed issue to Altium S.A. was resolved on the extraordinary general meeting on November 15, 2023. The directed issue has now been registered at the Swedish Companies Registration Office.

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 15 november 2023

Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on November 15, 2023. The following resolutions were passed at the meeting.
BioStock-PHI-CEO-reflects-on-the-company-momentum

BioStock: PHI’s CEO reflects on the Company’s momentum

BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.
See All News